WO2002080882A1 - Skin care cream containing omega-3 - Google Patents
Skin care cream containing omega-3 Download PDFInfo
- Publication number
- WO2002080882A1 WO2002080882A1 PCT/NO2002/000104 NO0200104W WO02080882A1 WO 2002080882 A1 WO2002080882 A1 WO 2002080882A1 NO 0200104 W NO0200104 W NO 0200104W WO 02080882 A1 WO02080882 A1 WO 02080882A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- emulsion
- oil
- omega
- water
- skin care
- Prior art date
Links
- 235000020660 omega-3 fatty acid Nutrition 0.000 title claims abstract description 36
- 239000006071 cream Substances 0.000 title description 7
- 229940012843 omega-3 fatty acid Drugs 0.000 claims abstract description 33
- 239000006014 omega-3 oil Substances 0.000 claims abstract description 29
- 238000002360 preparation method Methods 0.000 claims abstract description 21
- 238000000034 method Methods 0.000 claims abstract description 11
- 239000000839 emulsion Substances 0.000 claims description 78
- 239000003921 oil Substances 0.000 claims description 22
- 235000019198 oils Nutrition 0.000 claims description 22
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 16
- 235000021323 fish oil Nutrition 0.000 claims description 13
- 150000002632 lipids Chemical class 0.000 claims description 13
- 239000007762 w/o emulsion Substances 0.000 claims description 11
- 239000000203 mixture Substances 0.000 claims description 9
- 239000007764 o/w emulsion Substances 0.000 claims description 7
- 235000012716 cod liver oil Nutrition 0.000 claims description 4
- 239000003026 cod liver oil Substances 0.000 claims description 4
- CYQFCXCEBYINGO-IAGOWNOFSA-N delta1-THC Chemical compound C1=C(C)CC[C@H]2C(C)(C)OC3=CC(CCCCC)=CC(O)=C3[C@@H]21 CYQFCXCEBYINGO-IAGOWNOFSA-N 0.000 claims description 4
- 239000012141 concentrate Substances 0.000 claims description 3
- 235000015112 vegetable and seed oil Nutrition 0.000 claims description 3
- 239000008158 vegetable oil Substances 0.000 claims description 3
- 239000002884 skin cream Substances 0.000 abstract description 19
- XSQUKJJJFZCRTK-UHFFFAOYSA-N Urea Chemical compound NC(N)=O XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 description 12
- 235000014113 dietary fatty acids Nutrition 0.000 description 7
- 239000000194 fatty acid Substances 0.000 description 7
- 229930195729 fatty acid Natural products 0.000 description 7
- 230000003647 oxidation Effects 0.000 description 7
- 238000007254 oxidation reaction Methods 0.000 description 7
- 239000004202 carbamide Substances 0.000 description 6
- 235000013877 carbamide Nutrition 0.000 description 6
- 150000004665 fatty acids Chemical class 0.000 description 6
- 239000000047 product Substances 0.000 description 6
- 241000251468 Actinopterygii Species 0.000 description 3
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 3
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 3
- -1 fatty acid compounds Chemical class 0.000 description 3
- 210000004185 liver Anatomy 0.000 description 3
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 2
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 2
- POJWUDADGALRAB-UHFFFAOYSA-N allantoin Chemical compound NC(=O)NC1NC(=O)NC1=O POJWUDADGALRAB-UHFFFAOYSA-N 0.000 description 2
- OVBPIULPVIDEAO-LBPRGKRZSA-N folic acid Chemical compound C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)N[C@@H](CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-LBPRGKRZSA-N 0.000 description 2
- IRHTZOCLLONTOC-UHFFFAOYSA-N hexacosan-1-ol Chemical compound CCCCCCCCCCCCCCCCCCCCCCCCCCO IRHTZOCLLONTOC-UHFFFAOYSA-N 0.000 description 2
- IPCSVZSSVZVIGE-UHFFFAOYSA-N hexadecanoic acid Chemical compound CCCCCCCCCCCCCCCC(O)=O IPCSVZSSVZVIGE-UHFFFAOYSA-N 0.000 description 2
- 239000004615 ingredient Substances 0.000 description 2
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 2
- LXCFILQKKLGQFO-UHFFFAOYSA-N methylparaben Chemical compound COC(=O)C1=CC=C(O)C=C1 LXCFILQKKLGQFO-UHFFFAOYSA-N 0.000 description 2
- GLDOVTGHNKAZLK-UHFFFAOYSA-N octadecan-1-ol Chemical compound CCCCCCCCCCCCCCCCCCO GLDOVTGHNKAZLK-UHFFFAOYSA-N 0.000 description 2
- LSTDYDRCKUBPDI-UHFFFAOYSA-N palmityl acetate Chemical compound CCCCCCCCCCCCCCCCOC(C)=O LSTDYDRCKUBPDI-UHFFFAOYSA-N 0.000 description 2
- 239000002245 particle Substances 0.000 description 2
- 235000020777 polyunsaturated fatty acids Nutrition 0.000 description 2
- QELSKZZBTMNZEB-UHFFFAOYSA-N propylparaben Chemical compound CCCOC(=O)C1=CC=C(O)C=C1 QELSKZZBTMNZEB-UHFFFAOYSA-N 0.000 description 2
- 235000021122 unsaturated fatty acids Nutrition 0.000 description 2
- 150000004670 unsaturated fatty acids Chemical class 0.000 description 2
- 239000011782 vitamin Substances 0.000 description 2
- 229940088594 vitamin Drugs 0.000 description 2
- 235000013343 vitamin Nutrition 0.000 description 2
- 229930003231 vitamin Natural products 0.000 description 2
- GVJHHUAWPYXKBD-IEOSBIPESA-N α-tocopherol Chemical compound OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-IEOSBIPESA-N 0.000 description 2
- CHHHXKFHOYLYRE-UHFFFAOYSA-M 2,4-Hexadienoic acid, potassium salt (1:1), (2E,4E)- Chemical compound [K+].CC=CC=CC([O-])=O CHHHXKFHOYLYRE-UHFFFAOYSA-M 0.000 description 1
- POJWUDADGALRAB-PVQJCKRUSA-N Allantoin Natural products NC(=O)N[C@@H]1NC(=O)NC1=O POJWUDADGALRAB-PVQJCKRUSA-N 0.000 description 1
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical group [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 1
- 208000024172 Cardiovascular disease Diseases 0.000 description 1
- 244000007835 Cyamopsis tetragonoloba Species 0.000 description 1
- UDIPTWFVPPPURJ-UHFFFAOYSA-M Cyclamate Chemical compound [Na+].[O-]S(=O)(=O)NC1CCCCC1 UDIPTWFVPPPURJ-UHFFFAOYSA-M 0.000 description 1
- ZAKOWWREFLAJOT-CEFNRUSXSA-N D-alpha-tocopherylacetate Chemical compound CC(=O)OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C ZAKOWWREFLAJOT-CEFNRUSXSA-N 0.000 description 1
- FPVVYTCTZKCSOJ-UHFFFAOYSA-N Ethylene glycol distearate Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCCOC(=O)CCCCCCCCCCCCCCCCC FPVVYTCTZKCSOJ-UHFFFAOYSA-N 0.000 description 1
- 239000004166 Lanolin Substances 0.000 description 1
- OVBPIULPVIDEAO-UHFFFAOYSA-N N-Pteroyl-L-glutaminsaeure Natural products C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)NC(CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-UHFFFAOYSA-N 0.000 description 1
- 235000021314 Palmitic acid Nutrition 0.000 description 1
- 239000004698 Polyethylene Substances 0.000 description 1
- 235000021355 Stearic acid Nutrition 0.000 description 1
- GSEJCLTVZPLZKY-UHFFFAOYSA-N Triethanolamine Chemical compound OCCN(CCO)CCO GSEJCLTVZPLZKY-UHFFFAOYSA-N 0.000 description 1
- OENHQHLEOONYIE-UKMVMLAPSA-N all-trans beta-carotene Natural products CC=1CCCC(C)(C)C=1/C=C/C(/C)=C/C=C/C(/C)=C/C=C/C=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C OENHQHLEOONYIE-UKMVMLAPSA-N 0.000 description 1
- 229960000458 allantoin Drugs 0.000 description 1
- 229940087168 alpha tocopherol Drugs 0.000 description 1
- 230000003110 anti-inflammatory effect Effects 0.000 description 1
- 239000003963 antioxidant agent Substances 0.000 description 1
- 230000003078 antioxidant effect Effects 0.000 description 1
- 235000006708 antioxidants Nutrition 0.000 description 1
- 235000010323 ascorbic acid Nutrition 0.000 description 1
- 239000011668 ascorbic acid Substances 0.000 description 1
- 229960005070 ascorbic acid Drugs 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 235000013734 beta-carotene Nutrition 0.000 description 1
- TUPZEYHYWIEDIH-WAIFQNFQSA-N beta-carotene Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CCCC1(C)C)C=CC=C(/C)C=CC2=CCCCC2(C)C TUPZEYHYWIEDIH-WAIFQNFQSA-N 0.000 description 1
- 239000011648 beta-carotene Substances 0.000 description 1
- 229960002747 betacarotene Drugs 0.000 description 1
- 229910052799 carbon Inorganic materials 0.000 description 1
- 125000004432 carbon atom Chemical group C* 0.000 description 1
- 239000004359 castor oil Substances 0.000 description 1
- 235000019438 castor oil Nutrition 0.000 description 1
- 229940049297 cetyl acetate Drugs 0.000 description 1
- 239000000625 cyclamic acid and its Na and Ca salt Substances 0.000 description 1
- ZAKOWWREFLAJOT-UHFFFAOYSA-N d-alpha-Tocopheryl acetate Natural products CC(=O)OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C ZAKOWWREFLAJOT-UHFFFAOYSA-N 0.000 description 1
- 230000001419 dependent effect Effects 0.000 description 1
- 235000015872 dietary supplement Nutrition 0.000 description 1
- 235000013601 eggs Nutrition 0.000 description 1
- 235000019197 fats Nutrition 0.000 description 1
- 229940013317 fish oils Drugs 0.000 description 1
- 235000019152 folic acid Nutrition 0.000 description 1
- 239000011724 folic acid Substances 0.000 description 1
- 229960000304 folic acid Drugs 0.000 description 1
- 235000003599 food sweetener Nutrition 0.000 description 1
- 239000003205 fragrance Substances 0.000 description 1
- FOYKKGHVWRFIBD-UHFFFAOYSA-N gamma-tocopherol acetate Natural products CC(=O)OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1 FOYKKGHVWRFIBD-UHFFFAOYSA-N 0.000 description 1
- ZEMPKEQAKRGZGQ-XOQCFJPHSA-N glycerol triricinoleate Natural products CCCCCC[C@@H](O)CC=CCCCCCCCC(=O)OC[C@@H](COC(=O)CCCCCCCC=CC[C@@H](O)CCCCCC)OC(=O)CCCCCCCC=CC[C@H](O)CCCCCC ZEMPKEQAKRGZGQ-XOQCFJPHSA-N 0.000 description 1
- 229940100608 glycol distearate Drugs 0.000 description 1
- 230000035876 healing Effects 0.000 description 1
- 235000014655 lactic acid Nutrition 0.000 description 1
- 239000004310 lactic acid Substances 0.000 description 1
- 229940039717 lanolin Drugs 0.000 description 1
- 235000019388 lanolin Nutrition 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- 230000010534 mechanism of action Effects 0.000 description 1
- 239000012528 membrane Substances 0.000 description 1
- 235000010270 methyl p-hydroxybenzoate Nutrition 0.000 description 1
- 239000004292 methyl p-hydroxybenzoate Substances 0.000 description 1
- 229960002216 methylparaben Drugs 0.000 description 1
- 229940105132 myristate Drugs 0.000 description 1
- WQEPLUUGTLDZJY-UHFFFAOYSA-N n-Pentadecanoic acid Natural products CCCCCCCCCCCCCCC(O)=O WQEPLUUGTLDZJY-UHFFFAOYSA-N 0.000 description 1
- GOQYKNQRPGWPLP-UHFFFAOYSA-N n-heptadecyl alcohol Natural products CCCCCCCCCCCCCCCCCO GOQYKNQRPGWPLP-UHFFFAOYSA-N 0.000 description 1
- QIQXTHQIDYTFRH-UHFFFAOYSA-N octadecanoic acid Chemical compound CCCCCCCCCCCCCCCCCC(O)=O QIQXTHQIDYTFRH-UHFFFAOYSA-N 0.000 description 1
- OQCDKBAXFALNLD-UHFFFAOYSA-N octadecanoic acid Natural products CCCCCCCC(C)CCCCCCCCC(O)=O OQCDKBAXFALNLD-UHFFFAOYSA-N 0.000 description 1
- 239000002674 ointment Substances 0.000 description 1
- 229920000573 polyethylene Polymers 0.000 description 1
- 239000000244 polyoxyethylene sorbitan monooleate Substances 0.000 description 1
- 235000010482 polyoxyethylene sorbitan monooleate Nutrition 0.000 description 1
- 229920000053 polysorbate 80 Polymers 0.000 description 1
- 229940068968 polysorbate 80 Drugs 0.000 description 1
- 235000010241 potassium sorbate Nutrition 0.000 description 1
- 239000004302 potassium sorbate Substances 0.000 description 1
- 229940069338 potassium sorbate Drugs 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 239000003755 preservative agent Substances 0.000 description 1
- 230000002335 preservative effect Effects 0.000 description 1
- 235000010232 propyl p-hydroxybenzoate Nutrition 0.000 description 1
- 239000004405 propyl p-hydroxybenzoate Substances 0.000 description 1
- 229960003415 propylparaben Drugs 0.000 description 1
- 239000008213 purified water Substances 0.000 description 1
- CVHZOJJKTDOEJC-UHFFFAOYSA-N saccharin Chemical compound C1=CC=C2C(=O)NS(=O)(=O)C2=C1 CVHZOJJKTDOEJC-UHFFFAOYSA-N 0.000 description 1
- 239000000901 saccharin and its Na,K and Ca salt Substances 0.000 description 1
- 208000017520 skin disease Diseases 0.000 description 1
- WXMKPNITSTVMEF-UHFFFAOYSA-M sodium benzoate Chemical compound [Na+].[O-]C(=O)C1=CC=CC=C1 WXMKPNITSTVMEF-UHFFFAOYSA-M 0.000 description 1
- 235000010234 sodium benzoate Nutrition 0.000 description 1
- 239000004299 sodium benzoate Substances 0.000 description 1
- 229960001462 sodium cyclamate Drugs 0.000 description 1
- 239000003381 stabilizer Substances 0.000 description 1
- 239000008117 stearic acid Substances 0.000 description 1
- 238000003756 stirring Methods 0.000 description 1
- 239000003765 sweetening agent Substances 0.000 description 1
- 229960000984 tocofersolan Drugs 0.000 description 1
- MWOOGOJBHIARFG-UHFFFAOYSA-N vanillin Chemical compound COC1=CC(C=O)=CC=C1O MWOOGOJBHIARFG-UHFFFAOYSA-N 0.000 description 1
- FGQOOHJZONJGDT-UHFFFAOYSA-N vanillin Natural products COC1=CC(O)=CC(C=O)=C1 FGQOOHJZONJGDT-UHFFFAOYSA-N 0.000 description 1
- 235000012141 vanillin Nutrition 0.000 description 1
- 235000019154 vitamin C Nutrition 0.000 description 1
- 239000011718 vitamin C Substances 0.000 description 1
- 235000019165 vitamin E Nutrition 0.000 description 1
- 239000011709 vitamin E Substances 0.000 description 1
- 239000000230 xanthan gum Substances 0.000 description 1
- 229920001285 xanthan gum Polymers 0.000 description 1
- 229940082509 xanthan gum Drugs 0.000 description 1
- 235000010493 xanthan gum Nutrition 0.000 description 1
- 239000002076 α-tocopherol Substances 0.000 description 1
- 235000004835 α-tocopherol Nutrition 0.000 description 1
- OENHQHLEOONYIE-JLTXGRSLSA-N β-Carotene Chemical compound CC=1CCCC(C)(C)C=1\C=C\C(\C)=C\C=C\C(\C)=C\C=C\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C OENHQHLEOONYIE-JLTXGRSLSA-N 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/36—Carboxylic acids; Salts or anhydrides thereof
- A61K8/361—Carboxylic acids having more than seven carbon atoms in an unbroken chain; Salts or anhydrides thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
- A61K8/04—Dispersions; Emulsions
- A61K8/06—Emulsions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/67—Vitamins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/92—Oils, fats or waxes; Derivatives thereof, e.g. hydrogenation products thereof
- A61K8/925—Oils, fats or waxes; Derivatives thereof, e.g. hydrogenation products thereof of animal origin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
Definitions
- the present invention relates to a skin care preparation (skin cream) in the form of an emulsion, which contains, among other ingredients, unsaturated fatty acids that are prevented from oxidising, and also to a method for preparing a skin cream of this kind.
- omega-3 fatty acids in the fish liver oil which contribute to this, although the mechanism(s) of action have not been charted.
- the omega-3 fatty acids are used to perform functions such as forming membranes, and they are known to have a beneficial effect on the skin and also to be anti-inflammatory.
- omega-3 fatty acids in skin care preparations/creams has been that on oxidation they develop an unpreventable rancid fish oil smell, and therefore there have been very few attempts to use omega-3 fatty acids in this way.
- one patent application which has described the use of omega-3 fatty acids in a skin care preparation is NO 19980711, which relates to a skin care preparation that requires the presence of urea (carbamide).
- the object of the invention is to draw advantage from the use of the carbamide in the skin care preparation.
- a skin care preparation (skin cream) which comprises fatty acids, specifically omega-3 fatty acids, which are protected against oxidation, so that the skin cream does not emit an odour after application to the skin. It is a further object to provide a skin cream having a much higher omega-3 fatty acid content than has been provided before, yet without the product oxidising and developing a rank odour, and also to provide a method for preparing a product of this kind.
- the present invention relates to a skin care preparation (skin cream) comprising, among other ingredients, unsaturated fatty acids (omega-3 fatty acids), and which is prepared in such a way that the omega-3 fatty acids do not oxidise, even after application to the skin.
- skin care preparation skin cream
- unsaturated fatty acids omega-3 fatty acids
- This is achieved by mixing two emulsions where one is a water-in-oil emulsion (emulsion I) containing no omega-3 fatty acids, and the other is an oil-in-water emulsion (emulsion II) containing omega-3 fatty acids.
- emulsion III oil-in-oil emulsion
- omega-3 fatty acids in this new emulsion are protected against oxidation because they are contained within small water particles, which in turn are surrounded by/dispersed in the homogeneous and continuous lipid phase from emulsion I, thereby preventing the product from turning rancid.
- FIG. 1 The figure shows emulsion III, which is a water-in-oil emulsion.
- the water is in the emulsion in the form of a dispersed phase (droplets), 2, 3, which is in a continuous lipid phase 1.
- About 15% of the water particles are from emulsion II 3, and contain omega-3 fatty acids 4.
- an emulsion (emulsion III) has been prepared according to the invention by mixing together two other emulsions (emulsion I and emulsion II).
- Emulsion I is a water-in-oil emulsion, e.g., a skin cream, which does not contain omega-3 fatty acids, and where the lipid content is relatively low, that is to say 15- 20%, preferably 17%.
- the water phase in this emulsion comprises from 80 to 85%, preferably 83%.
- Emulsion II is an oil-in-water emulsion where the oil comprises from 66 to 80%, preferably 80%, whilst the water phase comprises from 20 to 34%, preferably 20%.
- the oil phase in the emulsion is composed of marine oils or concentrates or mixtures thereof, or a mixture of marine oils and vegetable oils.
- the marine oil used is preferably cod liver oil, and most preferably omega-3 fatty acids. If the oil is a fish oil, the omega-3 fatty acid content of the fish oil may be from 10 to 85%, preferably 20-60%, and more preferably 40%.
- the high oil content gives an emulsion of this kind high viscosity, which appears to help prevent the auto- oxidation of the polyunsaturated fatty acids.
- emulsion I and emulsion II can be mixed in a given ratio, e.g., in a ratio of respectively (80- 90): (20: 10), and preferably in the ratio of 85:15.
- the two emulsions are mixed by adding emulsion II to emulsion I at room temperature, whereupon they are gently stirred together, preferably without admission of air, until there is a visible homogeneity.
- the result is a new emulsion, called emulsion III, which will be a water-in-oil emulsion ( Figure 1).
- emulsion III the oil phase from emulsion I will form a homogeneous and continuous lipid phase 1.
- the water in emulsion III will be dispersed in the continuous lipid phase in the form of droplets 2, 3, which are consequently prevented from coming into contact with one another.
- a major portion of the droplets 2 consists of water from emulsion I.
- the droplets 3 which are from emulsion II constitute a substantially smaller portion of emulsion III as result of the mixture ratio, and the fatty acids 4 from emulsion II are found inside these 3 water droplets, and, according to the inventor, they are thus prevented from oxidising.
- the lipid phases in emulsions I and II are incompatible, and therefore have no possibility of forming a homogeneous lipid phase. As far as the inventor knows, an emulsion of this kind has not previously been described. In what follows the invention will be illustrated by means of examples, which should by no means be understood as defining the limits of the invention.
- the example illustrates a skin cream according to the present invention which contains omega-3 fatty acids.
- a skin cream in the form of a water-in-oil emulsion (emulsion I) which does not contain omega-3 fatty acids is prepared, where the ratio between the lipid and the water phase is 17 and 85% respectively;
- an oil-in-water emulsion (emulsion II) is prepared, where the oil is fish oil containing omega-3 fatty acids, and where the ratio between the lipid and water phase is 80 and 20% respectively;
- emulsion I and emulsion II are mixed together by gentle stirring.
- the example illustrates a skin cream according to the present invention which contains omega-3 fatty acids.
- An emulsion I skin cream: Hudpleiekrem, ScanHall A.s
- the skin cream consists of about 83% purified water and the following components: stearic acid, palmitic acid, isopropylene myristate, propylene glycol, ceryl alcohol, glycol distearate, polysorbate 80, cetyl acetate, acetylate lanolin alcohol, stearyl alcohol, alcohol denate, triethanolamine, methylparaben, tocopheryl acetate, lactic acid, propyl paraben, fragrance, allantoin and polyethylene glycol-40 hydrogenated castor oil.
- emulsion II an oil-in-water emulsion which has the viscosity of a paste is used as emulsion II. During its preparation, this product has not been in contact with the air, which means that there has not been any oxidation of the fish oil in the product. This emulsion contains in addition vitamins E and C which act as anti- oxidants and play a major role in the defence against free radicals.
- Emulsion II contains in addition vitamins E and C which act as anti- oxidants and play a major role in the defence against free radicals.
- CoromarTM ScanHall A.s
- fish oil comprising 40% omega-3 fatty acids, in addition to water, eggs, vitamins (ascorbic acid, alpha-tocopherol, folic acid), flavouring (vanillin), preservative (potassium sorbate, sodium benzoate) sweetener (acesulpham K, sodium cyclamate, sodium saccharinate), acidity regulator (citric acid), stabiliser (guar seed powder, xanthan gum) and beta-carotene).
- vitamins ascorbic acid, alpha-tocopherol, folic acid
- flavouring vanillin
- preservative potassium sorbate, sodium benzoate
- sweetener acesulpham K, sodium cyclamate, sodium saccharinate
- acidity regulator citric acid
- stabiliser guar seed powder, xanthan gum
- beta-carotene beta-carotene
- a skin cream as disclosed in Example 2 was tested for odour after application to the skin.
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Birds (AREA)
- Epidemiology (AREA)
- Chemical & Material Sciences (AREA)
- Dermatology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Zoology (AREA)
- Engineering & Computer Science (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Emergency Medicine (AREA)
- Dispersion Chemistry (AREA)
- Cosmetics (AREA)
Abstract
Description
Claims
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
NO20011327 | 2001-03-15 | ||
NO20011327A NO313934B1 (en) | 2001-03-15 | 2001-03-15 | Skin care agent in the form of an emulsion, process for making said skin care agent, and use thereof |
Publications (1)
Publication Number | Publication Date |
---|---|
WO2002080882A1 true WO2002080882A1 (en) | 2002-10-17 |
Family
ID=19912260
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/NO2002/000104 WO2002080882A1 (en) | 2001-03-15 | 2002-03-13 | Skin care cream containing omega-3 |
Country Status (2)
Country | Link |
---|---|
NO (1) | NO313934B1 (en) |
WO (1) | WO2002080882A1 (en) |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5589508A (en) * | 1991-10-11 | 1996-12-31 | Fresenius Ag | Use of an emulsion to prepare an intravensously administered medicament for treating skin diseases |
US5874470A (en) * | 1987-10-09 | 1999-02-23 | B. Braun Melsungen Ag | Isotonic fat emulsion containing omega-3-fatty acids and use thereof |
US6149900A (en) * | 1997-10-03 | 2000-11-21 | L'oreal S.A. | Stable W/O/W emulsion and its use as cosmetic and/or dermatological composition |
-
2001
- 2001-03-15 NO NO20011327A patent/NO313934B1/en not_active IP Right Cessation
-
2002
- 2002-03-13 WO PCT/NO2002/000104 patent/WO2002080882A1/en not_active Application Discontinuation
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5874470A (en) * | 1987-10-09 | 1999-02-23 | B. Braun Melsungen Ag | Isotonic fat emulsion containing omega-3-fatty acids and use thereof |
US5589508A (en) * | 1991-10-11 | 1996-12-31 | Fresenius Ag | Use of an emulsion to prepare an intravensously administered medicament for treating skin diseases |
US6149900A (en) * | 1997-10-03 | 2000-11-21 | L'oreal S.A. | Stable W/O/W emulsion and its use as cosmetic and/or dermatological composition |
Also Published As
Publication number | Publication date |
---|---|
NO20011327D0 (en) | 2001-03-15 |
NO20011327L (en) | 2002-09-16 |
NO313934B1 (en) | 2002-12-30 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US4454159A (en) | Dermatological treatment preparations | |
JP3103430B2 (en) | Fat-soluble antioxidant mixture | |
US5079003A (en) | Skin lotions and creams | |
US4919923A (en) | Cosmetic emulsions having improved flow behavior | |
ES2196333T5 (en) | COMPOSITIONS OF VEGETABLE OILS. | |
EP0047804A1 (en) | Water-in-oil emulsions and process for preparing same | |
JPS5910511A (en) | Aqueous solution containing fat-soluble substance | |
EP0084341B1 (en) | Emulsion-type composition for external use | |
Berdick | The role of fats and oils in cosmetics | |
JPS591405A (en) | Emulsifiable composition | |
DE1492149A1 (en) | Mass for the treatment and care of the skin | |
JPH0747524B2 (en) | Vegetable fat composition | |
AU656959B2 (en) | Spread | |
JP3887182B2 (en) | Multi-layered emulsion for stabilizing skin useful substance and its external preparation for skin | |
Bhargava | The present status of formulation of cosmetic emulsions | |
WO1999039682A2 (en) | Lipid mixtures and their use | |
WO2002080882A1 (en) | Skin care cream containing omega-3 | |
DE69114796T2 (en) | Antioxidant system based on a basic amino acid and a tocopherol. | |
JPS6344842A (en) | Oil-in-water emulsified fat composition | |
JP2015044780A (en) | Solubilizer | |
JPS61227517A (en) | Skin cosmetic | |
JPH06271420A (en) | Water absorption improver for cosmetics or external preparations for skin | |
RU94011006A (en) | Natural wax-propolis cream emulsion | |
RU2120275C1 (en) | Cream for skin care (versions) | |
JPH0145444B2 (en) |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A1 Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ OM PH PL PT RO RU SD SE SG SI SK SL TJ TM TN TR TT TZ UA UG US UZ VN YU ZA ZM ZW |
|
AL | Designated countries for regional patents |
Kind code of ref document: A1 Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG |
|
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
DFPE | Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101) | ||
REG | Reference to national code |
Ref country code: DE Ref legal event code: 8642 |
|
122 | Ep: pct application non-entry in european phase | ||
NENP | Non-entry into the national phase |
Ref country code: JP |
|
WWW | Wipo information: withdrawn in national office |
Country of ref document: JP |